Related Experiment Video
Updated: Nov 16, 2025

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
RIPK3 Activates MLKL-mediated Necroptosis and Inflammasome Signaling during Streptococcus Infection
Hua-Rong Huang1,2, Soo Jung Cho1, Rebecca M Harris1
1Department of Medicine, Pulmonary and Critical Care, Weill Cornell Medicine, New York, New York.
Abstract:
Community-acquired pneumonia is the most common type of pneumonia and remains a leading cause of morbidity and mortality worldwide. Although many different pathogens can contribute to pneumonia, Streptococcus pneumoniae is one of the common bacterial pathogens that underlie community-acquired pneumonia. RIPK3 (receptor-interacting protein kinase 3) is widely recognized as a key modulator of inflammation and cell death. To elucidate a potential role of RIPK3 in pneumonia, we examined plasma from healthy control subjects and patients positive for streptococcal pneumonia. In human studies, RIPK3 protein concentrations were significantly elevated and were identified as a potential plasma marker of pneumococcal pneumonia. To expand these findings, we used an in vivo murine model of pneumococcal pneumonia to demonstrate that RIPK3 deficiency leads to reduced bacterial clearance, severe pathological damage, and high mortality. Our results illustrated that RIPK3 forms a complex with RIPK1, MLKL (mixed-lineage kinase domain-like protein), and MCU (mitochondrial calcium uniporter) to induce mitochondrial calcium uptake and mitochondrial reactive oxygen species(mROS) production during S. pneumoniae infection. In macrophages, RIPK3 initiated necroptosis via the mROS-mediated mitochondrial permeability transition pore opening and NLRP3 inflammasome activation via the mROS-AKT pathway to protect against S. pneumoniae. In conclusion, our study demonstrated a mechanism by which RIPK3-initiated necroptosis is essential for host defense against S. pneumoniae.
Insights
Receptor-interacting protein kinase 3 (RIPK3) is crucial for fighting Streptococcus pneumoniae pneumonia. RIPK3 deficiency worsens lung damage and mortality, highlighting its essential role in host defense against this common bacterial pneumonia.
Area of Science:
- Immunology
- Cell Biology
- Infectious Diseases
Background:
- Community-acquired pneumonia (CAP) is a major global health concern, with *Streptococcus pneumoniae* being a primary bacterial cause.
- Receptor-interacting protein kinase 3 (RIPK3) is a known regulator of inflammation and cell death pathways.
- The specific role of RIPK3 in the context of pneumococcal pneumonia remains largely unexplored.
Purpose of the Study:
- To investigate the role of RIPK3 in host defense against *Streptococcus pneumoniae* infection.
- To determine if RIPK3 can serve as a diagnostic marker for pneumococcal pneumonia.
Main Methods:
- Analysis of RIPK3 protein levels in plasma from human patients with streptococcal pneumonia and healthy controls.
- Utilized a murine model of *Streptococcus pneumoniae* pneumonia to assess the impact of RIPK3 deficiency.
- Investigated molecular mechanisms involving RIPK3, RIPK1, MLKL, MCU, mROS, and the NLRP3 inflammasome in macrophages.
Main Results:
- Elevated RIPK3 protein concentrations were observed in patients with pneumococcal pneumonia, suggesting its potential as a plasma biomarker.
- RIPK3-deficient mice exhibited impaired bacterial clearance, increased lung pathology, and significantly higher mortality rates.
- RIPK3 was found to complex with RIPK1, MLKL, and MCU, promoting mitochondrial calcium uptake and mROS production, crucial for activating necroptosis and the NLRP3 inflammasome via the mROS-AKT pathway.
Conclusions:
- RIPK3 plays a critical role in host defense against *Streptococcus pneumoniae* infection.
- RIPK3-mediated necroptosis is essential for controlling pneumococcal pneumonia by initiating mROS production and NLRP3 inflammasome activation.
- RIPK3 represents a potential therapeutic target and diagnostic marker for pneumococcal pneumonia.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
08:15Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of the Unfolded Protein Response
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway